Indian Government, Pfizer To Resolve Issues Over Vaccine Indemnity

Precautionary Dose Of Covid 19 Vaccine, Precautionary Dose Of Covid Vaccine, vaccine certificate compulsory, covid-19 vaccination of children ,Children COVID Vaccine Registration ,third vaccine dose, Covaxin For Kids, COVID in fully vaccinated peopleThird COVID-19 Vaccine Dose, Johnson & Johnson’s Vaccine, Covid vaccine trial on children, viral shedding, comirnaty, Sanofi-GSK COVID-19 vaccine, COVID vaccine her immunity, Delta Plus Variant Escape Vaccines, Johnson and Johnson vaccine ,Johnson and Johnson vaccine ,Trials Of Covavax On Children, Janssen Vaccine, janssen-vaccine, Heart Inflammation Risk Warning, pfizer vaccine india ,Best COVID Vaccine, mRNA COVID-19 vaccine, Pfizer vaccine for children, Punjab Students Planning To Go Abroad ,vaccine free ,COVID-19 vaccine after effect Pfizer and BioNTech Vaccine For Children, COVID vaccine start working, Covaxin trials on children ,Two COVID-19 Vaccine Doses Same Day, Pfizer-BioNTech Vaccine For Adolescents, slot for COVID-19 vaccination ,Moderna Pfizer Turns Down States Vaccine,India-Pfizer ,vaccine for children ,Sputnik Light ,Delayed Second Pfizer COVID-19 Shot, Pfizer Vaccine, rare COVID vaccine side-effects, Biological E. Vaccine Candidate, valneva vaccine, woman hates needles , Pfizer Donates DrugsVaccination for pregnant women ,COVAXIN ,COVID-19 reinfection ,co-win ,vaccine registration ,COVID-19 Vaccine For Below 18 Years, Free COVID-19 Vaccination ,Covishield Vaccine Open Market Price, Free COVID-19 vaccine ,COVID19 Vaccination Phase 3 ,18 years above eligible ,Priority Vaccines For Journalists ,Sputnik V Vaccine ,anti-rabies vaccine ,double shots of covid-19 vaccine ,100-Year-Old Woman vaccinated ,Bollywood stars COVID-19 vaccine ,Germany suspends AstraZeneca, After effects of COVID-19 infection ,Oxford Vaccine Europe Ban, Johnson Vaccine, cowin app children registration, What Is Corbevax
India-Pfizer: The Indian Government and Pfizer are seeking to resolve tensions over a demand by the U.S. vaccine manufacturer. The company sought protection from any claims against any serious side-effects of the vaccine.

India has not given an indemnity to any manufacturer of Coronavirus vaccine against the costs of compensation for severe side effects. This is a condition Pfizer has obtained in the countries where its shots have been used widely, such as the U.S. and Britain. But reportedly, some of the legal protection is still an option as India and Pfizer work to reach a deal on the vaccine.

India-Pfizer seek to resolve the dispute

It is critical for India’s central government to reach an agreement with Pfizer. The Indian Government is reportedly struggling to secure the required amount of COVID-19 vaccine doses as daily cases exceed 250,000. 98 per cent of India’s population still remains prone to infection.

According to media reports, India’s foreign minister, S. Jaishankar plans to visit the U.S. in the coming days to ease Pfizer’s concerns. He might offer the company some form of lawsuits. In exchange, the company must provide additional assistance with distributing its shots in India.

Reports state that the two parties discussed the issue of indemnity this week but have not reached a resolution yet. A Pfizer spokeswoman revealed to leading dailies that the company is still in talks with India on a deal. The two parties have not reached a deadlock but Pfizer is hopeful about reaching an agreement. The company has been consistent in its position on indemnity and will not change its approach for a deal with India, they said.

India pledged last month to accelerate the process of approvals for vaccine makers abroad. These makers include Pfizer, Moderna and Johnson & Johnson. However, none of them has sought permission from India’s drug regulator to sell their vaccine here.

As per the government data of May 22, 2021,  India has administered 19,32,17,819 COVID-19 vaccinations have been done.

We request you to support our award-winning journalism by making a financial contribution towards our efforts. Your funds will ensure we can continue to bring you amazing stories of women, and the impact they are making and spotlight half the country's population because they deserve it.

By proceeding, you are agreeing to our Terms of Service .View our FAQs and Support page .